Toby S. Edelman has been representing older people in long-term care facilities since 1977. As a Senior Policy Attorney with the Center for Medicare Advocacy since January 2000, Ms. Edelman provides training, research, policy analysis, … [Read more...] about Toby S. Edelman, Ed. M., JD – Senior Policy Attorney
Search Results for: antipsychotic drugs
Transition Memorandum for Biden Administration Department of Health & Human Services (HHS)
December 2020 Links to detailed sections below I. Introduction II. Executive Summary: Administrative Measures III. Medicare Platform: Legislative Agenda IV. Administrative Action: Full Recommendations Strengthen Protections for Nursing … [Read more...] about Transition Memorandum for Biden Administration Department of Health & Human Services (HHS)
CMA Alert | October 22, 2020
Medicare Plan Finder Problems Emerge – At Least Three SHIP Programs Cautioning People to Delay Enrollment until Problems ResolvedDismantling the Affordable Care Act Would Harm Medicare and Medicare Beneficiaries: Spotlight on Closing the Part D … [Read more...] about CMA Alert | October 22, 2020
Long-Term Care Policy: Trump vs. Biden
The Center for Medicare Advocacy offers the following comparison of the presidential campaigns’ long-term care policies. For the Biden campaign, the Center looks at the Democratic Party’s 2020 platform,[1] the official campaign website,[2] … [Read more...] about Long-Term Care Policy: Trump vs. Biden
Lawmakers Must Be Cautious about Recommendations from a New Industry Report on Nursing Home Closures
Joint Statement from the Long Term Care Community Coalition and the Center for Medicare Advocacy Feb. 28, 2020 - LeadingAge, a trade association for non-profit nursing homes, has released a report on nursing home closures and trends between June … [Read more...] about Lawmakers Must Be Cautious about Recommendations from a New Industry Report on Nursing Home Closures
CMA Alert – October 17, 2019
Center for Medicare Advocacy Board President Judith Feder Testifies at Drug Pricing Hearing Administration’s “Public Charge” Rule [Temporarily?] Blocked Drug Company Sued Over Kickbacks for Off-Label Marketing of Psychotropic Drug for Nursing … [Read more...] about CMA Alert – October 17, 2019
Drug Company Sued Over Kickbacks for Off-Label Marketing of Psychotropic Drug for Nursing Home Residents to Pay Over $115 Million
Background When the Centers for Medicare & Medicaid Services (CMS) launched a national campaign to reduce the off-label prescribing of antipsychotic drugs for nursing home residents in 2012, Avanir Pharmaceuticals directed its sales force to … [Read more...] about Drug Company Sued Over Kickbacks for Off-Label Marketing of Psychotropic Drug for Nursing Home Residents to Pay Over $115 Million
CMA Alert – September 19, 2019
Senator Brown Leads Charge for Better Oversight of Medicare Advantage Plans Health Care Sabotage Takes its Toll Center for Medicare Advocacy Submits Comments Opposing the Administration’s Proposed Roll Back of Nursing Home Standards Rule … [Read more...] about CMA Alert – September 19, 2019
Center for Medicare Advocacy Submits Comments Opposing the Administration’s Proposed Roll Back of Nursing Home Standards
On September 15, 2019, the Center for Medicare Advocacy (the Center) and the Long Term Care Community Coalition (LTCCC) submitted comments opposing the Trump Administration’s proposed rule to revise the nursing home Requirements of Participation. The … [Read more...] about Center for Medicare Advocacy Submits Comments Opposing the Administration’s Proposed Roll Back of Nursing Home Standards
Center Comments on Proposed Rule to Revise Nursing Home Requirements of Participation
September 15, 2019 Administrator Seema Verma Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-3347-P P.O. Box 8010 Baltimore, MD 21244-1850 Re: CMS-3374-P; Federal Register, Vol. 84, No. … [Read more...] about Center Comments on Proposed Rule to Revise Nursing Home Requirements of Participation